In addition, both NZ001 and sorafenib treatment induced a significant decrease of MVD, increased intratumoral hypoxia and elevated total-MET levels in HCC tissues compared with the controls (Fig. 5b; Additional file 3: Figure S9A-C). The gene discussed is MET; the disease is hepatocellular carcinoma.